BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29426008)

  • 21. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial.
    Petterson SC; Plancher KD
    Knee Surg Sports Traumatol Arthrosc; 2019 Jun; 27(6):1992-2002. PubMed ID: 30159738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study.
    Möller I; Rodas G; Villalón JM; Rodas JA; Angulo F; Martínez N; Vergés J
    J Transl Med; 2023 Jun; 21(1):423. PubMed ID: 37386594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CO
    Guo MH; Zhao L; Wu F; Du J; Ding CH; Ge JH; Tan MT; Lao LX; Shen XY; Cheng K
    Chin J Integr Med; 2020 Aug; 26(8):568-576. PubMed ID: 31974753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee.
    Petrella RJ; Petrella M
    J Rheumatol; 2006 May; 33(5):951-6. PubMed ID: 16652426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee.
    Maksymowych WP; Russell AS; Chiu P; Yan A; Jones N; Clare T; Lambert RG
    Arthritis Res Ther; 2012 Oct; 14(5):R206. PubMed ID: 23036475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Rondanelli M; Braschi V; Gasparri C; Nichetti M; Faliva MA; Peroni G; Naso M; Iannello G; Spadaccini D; Miraglia N; Putignano P; Alalwan TA; Perna S
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31470599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.
    Bond M; Davis A; Lohmander S; Hawker G
    Osteoarthritis Cartilage; 2012 Jun; 20(6):541-7. PubMed ID: 22425883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synovial fluid alpha-melanocyte-stimulating hormone may act as a protective biomarker for primary knee osteoarthritis.
    Guan J; Li Y; Ding LB; Liu GY; Zheng XF; Xue W; Wang HJ
    Discov Med; 2019 Jan; 27(146):17-26. PubMed ID: 30721648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and synovial fluid cytokine profiling in hip osteoarthritis: distinct from knee osteoarthritis and correlated with pain.
    Ren G; Lutz I; Railton P; Wiley JP; McAllister J; Powell J; Krawetz RJ
    BMC Musculoskelet Disord; 2018 Feb; 19(1):39. PubMed ID: 29402254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.
    Karsdal MA; Byrjalsen I; Alexandersen P; Bihlet A; Andersen JR; Riis BJ; Bay-Jensen AC; Christiansen C;
    Osteoarthritis Cartilage; 2015 Apr; 23(4):532-43. PubMed ID: 25582279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study.
    Mazières B; Hucher M; Zaïm M; Garnero P
    Ann Rheum Dis; 2007 May; 66(5):639-45. PubMed ID: 17204566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP
    Arthritis Res Ther; 2008; 10(4):R85. PubMed ID: 18667054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized clinical trial evaluating transdermal Ibuprofen for moderate to severe knee osteoarthritis.
    Varadi G; Zhu Z; Blattler T; Hosle M; Loher A; Pokorny R; Frey D; Carter SG
    Pain Physician; 2013; 16(6):E749-62. PubMed ID: 24284856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of UCMA levels in serum and synovial fluid with severity of knee osteoarthritis.
    Okuyan HM; Terzi MY; Ozcan O; Kalaci A
    Int J Rheum Dis; 2019 Oct; 22(10):1884-1890. PubMed ID: 31424176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.
    Frakes EP; Risser RC; Ball TD; Hochberg MC; Wohlreich MM
    Curr Med Res Opin; 2011 Dec; 27(12):2361-72. PubMed ID: 22017192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Argan Oil Consumption on Knee Osteoarthritis Symptoms: A Randomized Controlled Clinical Trial.
    Essouiri J; Harzy T; Benaicha N; Errasfa M; Abourazzak FE
    Curr Rheumatol Rev; 2017; 13(3):231-235. PubMed ID: 28699499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study.
    Lopes de Jesus CC; Dos Santos FC; de Jesus LMOB; Monteiro I; Sant'Ana MSSC; Trevisani VFM
    PLoS One; 2017; 12(7):e0179185. PubMed ID: 28738079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind randomized controlled trial appraising the symptom-modifying effects of colchicine on osteoarthritis of the knee.
    Aran S; Malekzadeh S; Seifirad S
    Clin Exp Rheumatol; 2011; 29(3):513-8. PubMed ID: 21640042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis.
    Prior MJ; Harrison DD; Frustaci ME
    Curr Med Res Opin; 2014 Nov; 30(11):2377-87. PubMed ID: 25121804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.